Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 412 followers
Latest posts
Last updated about 12 hours ago
It's BMS vs. Celgene investors once more after U.S. appeals court revives lawsuit
about 12 hours ago
A U.S. appeals court has revived a lawsuit filed by Celgene shareholders...
How consumerization is reshaping pharma marketing
about 12 hours ago
GLP-1s, AI and telemedicine are changing patient behavior. Learn what it means...
Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision
about 12 hours ago
With the European Union formally reversing its marketing authorization for rare disease...
BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
about 13 hours ago
In a historic breakthrough for targeted protein degradation, BMS has secured the...
A genomics library for the AI era
about 13 hours ago
This week on "The Top Line," Fierce’s Fraiser Kansteiner sits down with...
Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
about 14 hours ago
As Legend Biotech became profitable, the company is navigating Carvykti's next phase...
It's crunch time for Karyopharm as it faces potential default next month
1 day ago
With its reserves depleted, a debt payment due in four weeks and...
AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
1 day ago
AstraZeneca’s newly approved blood pressure drug Baxfendy does not clear the bar...
Obesity not a 'zero-sum game' as patients crave optionality, Novo CEO says: Reuters
1 day ago
As the massive market for GLP-1 weight-loss drugs continues to come into...
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
1 day ago
EVERSANA INTOUCH’s CEO explains why the convergence of AI, creativity and commercialization...
Neurocrine stands by blockbuster hopeful Vykat XR as Prader-Willi docs raise potential safety flags
1 day ago
Roughly a year and a half after the approval of Vykat XR...
Abbott to pump up blood supply with $1M college sports prize amid US crisis
1 day ago
Abbott is again tapping into the competitive spirit of Big Ten universities...